CN109331069A - Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection - Google Patents
Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection Download PDFInfo
- Publication number
- CN109331069A CN109331069A CN201811491752.7A CN201811491752A CN109331069A CN 109331069 A CN109331069 A CN 109331069A CN 201811491752 A CN201811491752 A CN 201811491752A CN 109331069 A CN109331069 A CN 109331069A
- Authority
- CN
- China
- Prior art keywords
- monkshood
- application
- alkaloid
- drug
- fungal infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 229930013930 alkaloid Natural products 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title claims abstract description 21
- 208000031888 Mycoses Diseases 0.000 title claims abstract description 20
- 150000003797 alkaloid derivatives Chemical class 0.000 title claims abstract description 20
- 206010017533 Fungal infection Diseases 0.000 title claims abstract description 18
- 241000173529 Aconitum napellus Species 0.000 title 1
- 241000227129 Aconitum Species 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims description 22
- 238000002347 injection Methods 0.000 claims description 19
- 239000007924 injection Substances 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 5
- 230000006978 adaptation Effects 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000233866 Fungi Species 0.000 description 31
- 201000011510 cancer Diseases 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000001857 anti-mycotic effect Effects 0.000 description 7
- 239000002543 antimycotic Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000002023 wood Substances 0.000 description 7
- 208000017667 Chronic Disease Diseases 0.000 description 6
- 238000005336 cracking Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000003513 alkali Substances 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000553739 Aconitum carmichaelii var. truppelianum Species 0.000 description 2
- 241001522129 Pinellia Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 206010052366 systemic mycosis Diseases 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000415078 Anemone hepatica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000037026 Invasive Fungal Infections Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 150000002952 aconitine derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000021245 head disease Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000008337 systemic blood flow Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to medical health fields, are related to traditional Chinese medicine monkshood in the new application of the drug of preparation treatment deep fungal infection, and in particular to new application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection.
Description
Divisional application
The application is a kind of original application " Chinese medicine for treating deep fungal infection " (application number: point 201510807777.3)
Case application, the applying date of original application are on November 20th, 2015.
Technical field
The invention belongs to medical health fields, are related to traditional Chinese medicine monkshood in preparation and treat the drug of deep fungal infection
New application, and in particular to new application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection.
Background technique
Nosomycosis is divided into superficial mycoses and deep mycosis two major classes by modern medicine.Superficial mycoses refers to skin angle
Albumen tissue (including cuticula, deck, hair etc.) infection.Deep mycosis is also studies of invasive fungal infections (IFD), refers to fungi
Human body is invaded, grows, breed in tissue, organ or blood, and lead to the disease of inflammatory reaction and tissue damage.In recent years,
Since malignant tumour, immune deficiency, transplant patient's number increase, a large amount of uses and invasive monitoring of broad-spectrum antibiotic with
The extensive utilization for the treatment of means, the sufferer of fungi deep infection are in continue ascendant trend, seriously threaten the life security of the mankind.But
It is considerably less to the research of fungi deep infection at present, and now on the market for treating the drug of fungi deep infection, often
Side effect is big, and long-time service damages organ, and curative effect is also undesirable, while generating many adverse reactions.Hair
A kind of bright people's earlier patent application " Chinese medicine for treating deep fungal infection " (application number: in 201510807777.3), is discussed
The method that gastrodia elata, the tuber of pinellia, monkshood are used to treat fungi, but because being related to multiple independent claims, auditor's sending
" first time notification of examiner's opinion " (it is single 2018110101913730) dispatch serial number: to think that claim 1-10 does not have
Property.Therefore the requirement of auditor is answered to carry out divisional application on the basis of former claim 8.
Pathway of Creation of the invention is since the research of Jin Dynasty name doctor Zhang Yuansu " headache case ", to crack China
Ancient times traditional culture " the theory of yin-yang and five elements (metal, wood, water, fire and earth) "." the theory of yin-yang and five elements (metal, wood, water, fire and earth) " is also the basis of ancient Chinese medicine theory.Because ancients are existence
Germ in yin channel is known as " yin is evil ", and " yin is evil " is divided into " damp evil " and " cold-evil " again.I is cracked the inspiration of " yin and yang xue "
Think: " yin channel " described in Chinese medicine inner " damp evil " be survive in vein to anoxic have tolerance anaerobic bacteria (including
Fungi (mould)), " cold-evil " is then mould (fungi).Because fungi is most strong in all anaerobic bacterias to the tolerance of anoxic, because
The final result mutually struggled against between this person and the intracorporal various germs of animal is that fungi is won, this is that is to say, bright fungi is only and leads
The real arch-criminal for causing the mankind and animal unusual death, is the principal element for leading to various chronic diseases and cancer.By " yin channel "
It is vein, is that the anaerobic bacteria that can be survived in vein based on fungi is inspired by " damp evil ", is the inspiration of fungi by " cold-evil ",
To show that " damp-resolving medicinal, cold-dispelling drug " has antimycotic effect.It is inspired again by the characteristic that mould happiness acid detests alkali, obtains botanical medicine
In it is containing alkaloids be antimycotic main chemical compositions, and opened by Chinese medicine " removing dampness by means of aromatics, pungent cold with dampness elimination, Wen Yihua "
Hair, show that the volatile oil in botanical medicine is also antimycotic chemical component.Monkshood pharmacological property is pungent, hot, cures mainly wind-dispelling cold-dampness paralysis, because
This monkshood has the function of dampness elimination dispelling cold, has antimycotic effect, alkaloid is main antimycotic active constituent.
Summary of the invention
The purpose of the present invention is to provide the new applications that monkshood is used to treat deep fungal infection, are characterized in particular in and provide monkshood
New application of the alkaloid in the drug for preparing anti-deep fungal infection.
Further, the present invention also provides the chemical component alkaloids for extracting monkshood, and injection is made using modern pharmaceutical method
Powder-injection.
Further, the present invention also provides the chemical component alkaloids that can extract monkshood to be made of modern pharmaceutical method
The powder-injection of injection.
The monkshood or Radix Aconiti Lateralis Preparata alkaloid are used for the drug of anti-deep fungal, and adaptation range includes: in Medicines, moves
The application of object pharmaceutical preparations.
Specific embodiment
New opplication of the monkshood alkaloid in the drug for preparing anti-deep fungal infection, it is characterised in that extract the chemistry of monkshood
The powder-injection of injection is made of modern pharmaceutical method for ingredients Biogenic alkali.
New opplication of the Radix Aconiti Lateralis Preparata alkaloid in the drug for preparing anti-deep fungal infection, it is characterised in that extract the chemistry of monkshood
The powder-injection of injection is made of modern pharmaceutical method for ingredients Biogenic alkali.
Division foundation
The claim of this divisional application be by parent application " a kind of Chinese medicine for treating deep fungal infection " (application number:
201510807777.3) it is recorded in the claim 8 in claims: using modern pharmaceutical method Rhizoma Gastrodiae, the tuber of pinellia, river
The alkaloid of crow is individually prepared into the powder-injection of injection.River of the foundation of the application division in former claim 8
Black alkaloid is prepared into the powder-injection of injection.
Increase and " extracts the powder-injection that injection is made of modern pharmaceutical method for Radix Aconiti Lateralis Preparata alkaloid." foundation see that female case is said
The record of bright book [0051] section: can substitute monkshood with monkshood, and monkshood be the sub- root of the rhizome of Chinese monkshood, and monkshood is female root of the rhizome of Chinese monkshood, monkshood,
Monkshood contains a variety of alkaloids, mainly various aconitines.
Creativeness and novelty of the invention
Since Pathway of Creation of the invention be the " yin-yang and five elements cracking Chinese ancient traditional culture " the theory of yin-yang and five elements (metal, wood, water, fire and earth) "
Theory " be also ancient Chinese medicine theory basis.Because germ of the existence in yin channel is known as " yin is evil " by ancients, " yin is evil " divides again
For " damp evil " and " cold-evil ".It will be argued that cracking for " yin and yang xue ": " yin channel " described in Chinese medicine inner " damp evil " is existence
The anaerobic bacteria (including fungi) for having tolerance to anoxic in vein, " cold-evil " are then fungi.Tolerance of the fungi to anoxic
It is most strong in all anaerobic bacterias, therefore the final result mutually struggled against between the intracorporal various germs of humans and animals is mould victory
Out, this is the principal element for leading to cancer that is to say, bright fungi is only the real arch-criminal for leading to the mankind and animal unusual death.
It will be argued that cracking for " five-element ": germ causes pathology after mutual restriction of five phases relationship then indicates human infection germ
The transfer process of reaction.Mutual restriction of five phases relationship are as follows: metal restricting wood, Wood restricts earth, earth restricting water, water restricting fire, fire restricting metal.I cracks " gold "
For the dissection figure of lung, " wood " indicates twelve channels and collaterals whole body distribution map, the i.e. distribution map of system vascular." soil " is the solution of liver
Figure is cutd open, " water " is the dissection figure of two kidneys and urinary system, and " fire " is the dissection figure of heart.
So I determines: ancient Chinese doctor has found the pathology transfer process of anaerobic bacteria (including mould) are as follows: respiratory tract
Infection (entering artery) → systemic blood circulation (head, hand, foot capillary end) → vena hepatica → renal vein → heart → lung
Vein.
The present invention has also obtained the verifying of modern western scientific medical to cracking for " the theory of yin-yang and five elements (metal, wood, water, fire and earth) ".Modern medicine is to deep
The research achievement of fungal infection disease can prove that I am theoretical to " yin-yang and five elements " and " damp evil ", cracking for " cold-evil " are correct
, also turn out that the inference that it will be argued that " anemofrigid cold " then refers to flu caused by having infected the mould in air is correct
's.Also turning out it will be argued that: the process from " wet poison disease " to " sympotoms caused by cold factors " is from superficial infection fungi to deep fungal infection
Pathological change process and fungi cause the pathological change process of various chronic diseases and fungi to lead to the process of cancer, institute
My inference, which is correct, to be proved to the research of fungi with modern western scientific medical.
But the viewpoint of modern western scientific medical thinks: fungal infection belongs to one kind of infectious diseases, and fungi is cancer, is immunized
The suprainfection of the patients such as defect, organ transplant, is the relationship of complication, and fungi is conditioned pathogen.
Creativeness of the invention and novelty are: I am by cracking to " yin-yang and five elements ", it is believed that fungi, which is only, to cause
The main pathogenic of various chronic diseases and cancer, and more than simple one of infectious diseases, nor cancer,
The suprainfection of the patients such as immune deficiency, organ transplant or the relationship of complication.And it is additionally considered that current people are thought in person
Those of carcinogenic factor be risk factor, that is, external cause in fact.When tissue, cell, blood, the organ of external cause damage human body
When, cause blood circulation to be obstructed, in the state of anoxic, induces intracorporal mould and cause various in damaged part mass propagation
Disease, and further result in cancer.
So applicant thinks that the fungi (mould) that modern western scientific medical is thought is a subbranch of infectious diseases
Viewpoint it is defective, modern western scientific medical think fungi and cancer relationship be the relationship of suprainfection, the relationship for being complication,
Fungi is that the viewpoint of conditioned pathogen also has limitation.Creativeness of the invention is: thinking that canceration is exactly to go mouldy in fact, cancer
It is exactly mould pathological change process from quantitative change to qualitative change, when the clinic for the pathological change process reflection that mould breeds in human body
Symptom is exactly various chronic diseases, so showing that creative conclusion be exactly fungi is exactly the master for leading to various chronic diseases and cancer
Want pathogenic factor.
The only anaerobism for just as the principle of fermentation, being various germs at the beginning and depositing, but can survive in vein
Bacterium, and only have the vitality of mould most strong in various anaerobic bacterias, destructive power is also most strong, and canceration is exactly that mould is from quantitative change to qualitative change
Process, the clinical symptoms embodied during this quantitative change are exactly the symptom of various chronic diseases.When there are cancer symptoms, in vivo
Only mould accounts for absolute leading position.Therefore fungi is the main pathogenic for leading to cancer, fungi be also cause it is various chronic
The main pathogenic of disease, fungi are also the main pathogenic for leading to the viscera diseases such as liver, spleen, pancreas, kidney,
It is the principal element for causing blood circulation to be obstructed, and the main pathogenic for causing digestive system function to decline, and causes
The main pathogenic of entire head disease.
The applicant is inspired by the characteristic that mould happiness acid detests alkali, show that the alkaloid that monkshood, monkshood contain is antimycotic
Main chemical compositions.
So the creativeness and novelty of drug provided by the invention are shown: the new pharmacological action of monkshood, monkshood is anti-
Fungal agents, the antimycotic main active chemical of monkshood, monkshood is alkaloid.
So Pathway of Creation of the invention is that ancient Chinese medicine theory is docked with modern western scientific medical theory, make ancient Chinese medicine
Theory is mutually authenticated between the two with modern western scientific medical theory, melts ancient Chinese medicine theory with modern western scientific medical theory
It can penetrate through, more make ancient Chinese medicine theory to going a step further before modern scientific theory.The research of Needham, Noel Joseph Terence Montgomery research institute of univ cambridge uk
" Science And Civilization in China " in speak of recorded in the Exploitation of the Works of Nature of SONG Yingxing many techniques be how application technology, how to give birth to
It produces, the dosage ratio etc. of each raw material, but does not illustrate the application principle of these technologies.Therefore Needham, Noel Joseph Terence Montgomery research institute thinks China
It is technology prosperity, science is not kept up with, and four invents by China are technologies rather than scientific.Because of the intension of science and technology
It is different.Science is to test with mathematics as a whole set of complete scientific system of representative, it is metaphysics, is abstract
's.And technology is the summary of labourer experience and wisdom in process of production.Traditional Chinese medicine is also in this way, failing always
The application principle of bright traditional Chinese medicine can not be said because traditional Chinese medicine cannot illustrate the active chemical of various Chinese medicines
Its bright medicinal principle, can not illustrate the mechanism and pharmacology of various plant combined medications.And invention solves these problems.
It is that fungi is cracked to pathogenic factor, makes medically many problems that can obtain reasonably logical parsing, to botanical medicine
The discovery of active chemical alkaloid and volatile oil illustrates the application principle of traditional Chinese medicine, and thus the present invention made in ancient times
Medical knowledge opinion is to going a step further before modern scientific theory.
Technical effect
It is safely and effectively that traditional Chinese medicine monkshood, monkshood, which have been clinically proven,.Drug provided by the invention is in tradition
The extract of bulk pharmaceutical chemicals based on herbal medicine, extracts monkshood or powder-injection is prepared separately into Radix Aconiti Lateralis Preparata alkaloid.Because the present invention provides
Drug chemistry definite ingredients, compared to traditional pharmaceutical methods, validity is obvious.
Claims (4)
1. application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection.
2. application as described in claim 1, it is characterised in that extract the chemical component alkaloid of monkshood using modern pharmaceutical side
The powder-injection of injection is made in method.
3. application as described in claim 1, it is characterised in that the chemical component alkaloid for extracting monkshood and (or) monkshood uses
The powder-injection of injection is made in modern pharmaceutical method.
4. the application as described in claims 1 or 2 or 3, it is characterised in that the monkshood and (or) Radix Aconiti Lateralis Preparata alkaloid are used for anti-depth
The adaptation range of the drug of portion's fungal infection includes: the application in terms of Medicines, animal drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811491752.7A CN109331069A (en) | 2015-11-20 | 2015-11-20 | Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811491752.7A CN109331069A (en) | 2015-11-20 | 2015-11-20 | Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection |
| CN201510807777.3A CN105343565A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine for treating deep fungal infection |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510807777.3A Division CN105343565A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine for treating deep fungal infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109331069A true CN109331069A (en) | 2019-02-15 |
Family
ID=55319724
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510807777.3A Pending CN105343565A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine for treating deep fungal infection |
| CN201811491859.1A Pending CN109602828A (en) | 2015-11-20 | 2015-11-20 | Application of the tuber of pinellia alkaloid in the drug for preparing anti-deep fungal infection |
| CN201811491752.7A Pending CN109331069A (en) | 2015-11-20 | 2015-11-20 | Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510807777.3A Pending CN105343565A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine for treating deep fungal infection |
| CN201811491859.1A Pending CN109602828A (en) | 2015-11-20 | 2015-11-20 | Application of the tuber of pinellia alkaloid in the drug for preparing anti-deep fungal infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (3) | CN105343565A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220280588A1 (en) * | 2019-08-06 | 2022-09-08 | Mingchun Xiao | Medicament for treating stroke caused by deep fungal infections |
| WO2021119966A1 (en) * | 2019-12-17 | 2021-06-24 | 肖鸣春 | Drug for treating digestive system mycosis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1176110A (en) * | 1996-09-06 | 1998-03-18 | 薛弘扬 | Tinea lotion |
-
2015
- 2015-11-20 CN CN201510807777.3A patent/CN105343565A/en active Pending
- 2015-11-20 CN CN201811491859.1A patent/CN109602828A/en active Pending
- 2015-11-20 CN CN201811491752.7A patent/CN109331069A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1176110A (en) * | 1996-09-06 | 1998-03-18 | 薛弘扬 | Tinea lotion |
Non-Patent Citations (2)
| Title |
|---|
| MAKIKO KOBAYASHI等: "The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine Part 2: Mechanism of the antiviral action", 《IMMUNOLOGY AND CELL BIOLOGY》 * |
| 吴国泰: "甘青乌头生物碱的提取、分离和药理活性研究", 《中国博士学位论文全文数据库 农业科技辑》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109602828A (en) | 2019-04-12 |
| CN105343565A (en) | 2016-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109432180A (en) | A kind of pharmaceutical composition for treating mould | |
| CN109331162A (en) | A kind of pharmaceutical composition for treating the phrenoblabia as caused by fungi | |
| CN109331069A (en) | Application of the monkshood alkaloid in the drug for preparing anti-deep fungal infection | |
| CN101584810B (en) | Medicine composition for treating gastritis and peptic ulcer and preparation method thereof | |
| CN103041251B (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN103230418B (en) | Mycelium extract for helicobacter pylori-resistant biological medicine and preparation technology thereof | |
| CN116115687B (en) | Traditional Chinese medicine composition for gout and preparation method and application thereof | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| Yang et al. | Utilizing data mining techniques to analyze traditional Chinese medicine patterns in patients with acute cardiorenal syndrome | |
| CN105434890A (en) | Radiation stomatitis treating traditional Chinese medicine composition | |
| CN105147971A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis | |
| CN103191348A (en) | Medicine composition for treating chronic prostatitis and preparation method thereof | |
| CN117045751A (en) | Medicinal liquor for treating rheumatic arthralgia and preparation method thereof | |
| CN103751620A (en) | Traditional Chinese medicine composition for treating heart-fire hyperactivity type recurrent oral ulcer | |
| WO2021119966A1 (en) | Drug for treating digestive system mycosis | |
| CN106138256A (en) | The Chinese medicine preparation of a kind of compound termitarium and application thereof | |
| CN103041252A (en) | Traditional Chinese medicine composition for treating acute bronchitis | |
| CN101732533A (en) | Anti-tumor biological traditional Chinese medicine preparation and preparation method thereof | |
| CN106963880A (en) | It is a kind of to treat external used medicine of recurrent oral ulceration and preparation method thereof | |
| CN105168959A (en) | Traditional Chinese medicine mixture for treating radioactive stomatitis | |
| CN106266205A (en) | A kind of for promoting the middle-aged and elderly people Chinese medicine formula of diabetic foot rehabilitation | |
| CN105169283A (en) | Traditional Chinese medicinal preparation for treating pediatric pyogenic tonsillitis | |
| CN104998155A (en) | Medicinal preparation for treating acne | |
| CN105055991A (en) | Medicinal preparation for treating acne | |
| CN101869679A (en) | Traditional Chinese medicine preparation capsule for treating ischemic stroke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190215 |